Adastra Holdings Ltd · CSE:XTRX

Adastra — Investor Presentation (October 2021)

16 slides from Adastra's investor presentation, October 2021

  1. Slide 1: Cannabis Through Art and Science

    CANNABIS THROUGH ART AND SCIENCE INVESTOR PRESENTATION | OCTOBER 2021 CSE: XTRX | FRA: D2EP

  2. Slide 2: Disclaimer

    DISCLAIMER Investors and prospective investors should rely only on the information contained in the disclosure filings (the “Filings”) of Adastra Holdings Ltd. (the “Company”). This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the information conta

  3. Slide 3: Investment Highlights

    INVESTMENT HIGHLIGHTS ROBUST SCIENTIFIC CAPABILITIES 1. 13,000 sq.ft. processing facility, combining co-located Chemia Analytics cannabis testing lab and COMPANY PROFILE Adastra Labs’ extraction systems 2. Under review by Health Canada for a Research Licence, enabling Adastra to legally possess and

  4. Slide 4: How We Became a Player in Canadian Cannabis

    HOW WE BECAME A PLAYER IN CANADIAN CANNABIS Adastra Labs receives Standard Processing License Phyto Extractions brand from Health Canada asset acquired PerceiveMD acquired Chemia Analytics receives analytical testing license Supply agreement Michael Forbes Name changed to Adastra from Heath Canada w

  5. Slide 5: A Platform for Accelerated Growth in Canada

    A PLATFORM FOR ACCELERATED GROWTH IN CANADA Trusted global leaders in pharma-quality, development and manufacturing of cannabis API, and derivative products EXTRACT Our extraction methodologies and industry-leading equipment are designed Adastra Labs to meet your product development requirements. IM

  6. Slide 6: Expertise That Differentiates

    EXPERTISE THAT DIFFERENTIATES SUPER/SUB SOLVENTLESS DRIED ETHANOL HYDROCARBON FULL SPECTRUM CRITICAL CO2 EXTRACTS FLOWER Capsules, Tinctures, Capsules, Tinctures, Concentrates, Add back for Hash, Rosin, Full Prerolls Vapes, Topicals, Vapes, Topicals, Vapes, Shatter/Wax, experience, Spectrum Beverage

  7. Slide 7: One of British Columbia's Most Popular Cannabis Brands

    ONE OF BRITISH COLUMBIA’S MOST POPULAR CANNABIS BRANDS British Columbia's Best Selling Cannabis Concentrates AVG, RANK BRAND PRODUCT SALES (30DAY)* PRICE 1 Afghan Black Pressed Hash (2g) $23.69 Vortex Cannabis Inc. 2 232 Series - Ice Cream Cake THCA Diamonds Live Resin (1g) $49.14 Kolab 3 Pink Kush

  8. Slide 8: Growing Product Portfolio and Availability

    GROWING PRODUCT PORTFOLIO AND AVAILABILITY Expanding Distribution with Provincial Wholesalers GROWTH DRIVERS AUG 2021 • New product introduction • New retail penetration • New channels • Optimize in-store visibility Available to MAY 2020 • Sales force expansion 1,400+ AUG 2020 PENDING retailers acro

  9. Slide 9: Adastra Labs

    ADASTRA LABS EXTRACTION Adastra Labs is a Health Canada Standard Processor (cannabis extraction, no cultivation), cannabis product formulator/manufacturer, and licensed cannabis sales (extracts, edibles and topicals) operator with a 13,000 sq. ft. facility located in Langley, BC Canada. Our hydrocar

  10. Slide 10: Chemia Analytics

    CHEMIA ANALYTICS IN-HOUSE TESTING LAB Chemia Analytics is Adastra’s in-house laboratory testing facility, licensed by Health Canada (since 2019), that conducts QA/ QC and compliance testing services for licensed producers of cannabis and cannabis products along with other services for high-quality p

  11. Slide 11: Perceive MD

    PERCEIVE MD ONE OF BRITISH COLUMBIA’S LEADING MEDICAL CANNABIS AND FORWARD-THINKING THERAPY CLINICS PerceiveMD is a multidisciplinary team-based, patient-focused center providing free, comprehensive assessments for medical COMPASSIONATE CARE “ Through acquiring PerceiveMD and its extensive team of i

  12. Slide 12: Building Momentum

    BUILDING MOMENTUM • Standard Processing Licence Received, 190% 1st HALF CO2 processing line commissioned Year-over-year 2020 • Vape cart sales commence growth $1.50M $1.24M $1.24M • Capacity added to production via 2nd HALF addition of cryo-ethanol extraction 2020 • Additional Product categories add

  13. Slide 13: Q2 2021 Financial Metrics

    Q2 2021 FINANCIAL METRICS Q2 2021 Q2 2020 % Change Revenue $1,241,763 $428,355 190% Cost of sales 696,122 213,236 Gross profit 545,641 215,119 154% Gross margin 44% 50% Loss from operations (101,787) (338,032) Net loss (509,890) (467,584) Net loss per share (0.01) (0.01) $1.2 M 190% $0.5 M 44% Reven

  14. Slide 14: Share Count Detail

    SHARE COUNT DETAIL Fully Diluted Shares Outstanding Total Shares (as of June 30, 2021) (in millions) Common Shares 43,334,100 Options 3,400,001 (weighted average exercise price of CAD$1.71) Warrants 8,335,992 (weighted average exercise price of CAD$1.80) Compensation Options / Warrants 24,067 Total

  15. Slide 15: Experienced Leadership Team

    EXPERIENCED LEADERSHIP TEAM Michael Forbes Bsc. Pharm, MBA Donald Dinsmore M.Sc Oliver Foeste CPA, CA CEO & Director COO & Director CFO § Pharmacist § Plant biochemist Invictus Accounting § Pharmadrug § Heart Rock Mountain Farms § Ageless Living § Sitka Weed Works § Clarity Cannabis § Honeycomb Cann

  16. Slide 16: Get In Touch With Us

    Get In Touch With Us MICHAEL FORBES,CEO & DIRECTOR michael@adastraholdings.ca +1 (250) 882-3784 DONALD DINSMORE,COO & DIRECTOR donald@adastraholdings.ca +1 (778) 793-9303 CSE: XTRX | FRA: D2EP

Adastra Holdings — Investor Presentation (October 2021) on 6ix